BetterLife Pharma Inc. filed its 20-F on May 31, 2023 for the period ending Jan 31, 2023. In this report its auditor, Meyers Norris Penny LLP - MNP LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0906 USD | +3.84% | -5.82% | +88.75% |
05-03 | BetterLife Pharma Inc. announced that it expects to receive CAD 0.5 million in funding | CI |
05-01 | BetterLife Pharma Advances IND-enabling Studies For BETR-001 | MT |
1st Jan change | Capi. | |
---|---|---|
+88.75% | 10.12M | |
+5.33% | 111B | |
+12.11% | 105B | |
-12.56% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-10.86% | 16.96B | |
+5.10% | 13.7B | |
+37.57% | 12.45B |
- Stock Market
- Equities
- BETRF Stock
- News BetterLife Pharma Inc.
- BetterLife Pharma Inc. Auditor Raises 'Going Concern' Doubt